Product Program year 2025 Source: CMS Open Payments

Hympavzi

Drug Immunology

NDC 0069-2151-01

Open in the dashboard

General payments

$481,206

1,560 payments

Research payments

$105,870

55 payments

Through program year 2025, $481,206 in general payments and $105,870 in research payments were reported against Hympavzi (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $469,546 1,430
2025 Research $105,870 55
2024 General $11,660 130

Breakdown

Who paid General payments · program years 2024–2025
  1. Pfizer Inc. $479,175 1,441 payments
  2. PBG Puerto Rico LLC $2,031 119 payments
Top recipients General payments · program year 2025
  1. Akshat Jain Pediatric Hematology-Oncology · Redlands, CA $72,375 15% · 56 payments
  2. Maissaa Janbain Hematology & Oncology · New Orleans, LA $36,218 8% · 22 payments
  3. Vivek Sharma Hematology & Oncology · Louisville, KY $27,318 6% · 26 payments
  4. Ashok Raj Pediatric Hematology-Oncology · Louisville, KY $25,451 5% · 24 payments
  5. Steven Pipe Pediatric Hematology-Oncology · Ann Arbor, MI $17,750 4% · 9 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatric Hematology-Oncology Pediatrics $236,886 51% · 121 practitioners
  2. Hematology & Oncology Internal Medicine $132,272 28% · 196 practitioners
  3. Hematology Internal Medicine $34,096 7% · 18 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $19,511 4% · 106 practitioners
  5. Nurse Practitioner, Pediatrics Nurse Practitioner $14,218 3% · 23 practitioners

The top 5 of 59 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $134,936 29% · 69 recipients
  2. Kentucky $54,777 12% · 43 recipients
  3. Louisiana $52,947 11% · 84 recipients
  4. Michigan $28,548 6% · 21 recipients
  5. Washington $18,693 4% · 3 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,560 general · 55 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record